This week, we will discuss the role of ApoE in determining the subtypes of C3 Glomerulopathy.
This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?
This week, we tag along with NephMadness. It will be hard to stay impartial while discussing the role of angiogenic and antiangiogenic factors in severe preeclampsia prognosis.
This week, during kidney month and NephMadness season, we will discuss the USRDS report as well as the ISN Global Kidney Health Atlas report from 2024.
Sinead Stoneman, recent NSMC graduate produced these two visual abstracts for this week’s #NephJC chat.
Some additional visual enjoyment related to the Humphreys study
Still wish @CellStemCell had chosen our cover art submission! Designed by @BuryLeah with inspiration from @Kohei_Uchimura #organoids #PikePseudotime pic.twitter.com/S2yb0qGjMW
— Ben Humphreys (@HumphreysLab) November 26, 2018
82k scTranscriptomes later excited to annouce that our kidney #organoid MS is now out in @CellStemCell ! A true team effort: @morris_lab @HaojiaWu @Kohei_Uchimura @ykirita @WUSTLmed @cziscience @humancellatlas https://t.co/LRyQxUip3D pic.twitter.com/7lHgNlBVkz
— Ben Humphreys (@HumphreysLab) November 15, 2018
